GET DAILY SIGNALSHorizon Technology Finance (HRZN) Q3 Earnings Show NII Rebound to $0.19 Per Share
Key Takeaways
- Horizon Technology Finance reported net investment income (NII) of $12.3 million, or $0.19 per basic share, for the third quarter of 2026, up from $0.11 per share in the prior quarter.
- Total investment income came in at $24.1 million, down from $26.3 million in the year-ago period, largely reflecting lower interest income on the debt portfolio.
- Net asset value (NAV) per share declined to $5.56, pressured by $11.3 million in net realized losses and $29.1 million in net unrealized depreciation tied to stressed investments.
- The debt portfolio expanded for a fourth consecutive quarter, with nine loans funded totaling $98.4 million, and backlog rose 14% sequentially to $351 million.
- Available liquidity stood at $210.9 million, while net leverage remained well below the company's target at 82%.
- For additional detail, explore HRZN's Major News, Today's Price Move, Price Targets, and Forecast on dedicated pages.
- Discover automated trading strategies and market insights by exploring Trending AI Robots.
Putting the Quarter in Context
Horizon Technology Finance, a business development company focused on secured venture debt to technology and life sciences companies, is working through an important period after its April 2026 merger with Monroe Capital Corporation. This third quarter represents the first full reporting period for the combined platform, so the results offer a useful test of whether the larger scale can support steady income growth. From my perspective, the report stands out for two main reasons: whether NII is moving back toward better dividend coverage and whether credit quality is holding up after some earlier stress. With a floating-rate loan book and a focus on growth-stage borrowers, the quarter also gives a sense of how venture lending is performing in an environment where funding remains concentrated around larger AI-related names.
The Reported Numbers
For the third quarter ended September 30, 2026, Horizon posted NII of $12.3 million, or $0.19 per basic share. That marked a sequential improvement from $0.11 per share in the second quarter, though it remained below the $0.32 per share recorded a year earlier. NII came in slightly above consensus estimates. Total investment income reached $24.1 million, which was a bit below expectations and down from $26.3 million in the same quarter last year, mainly because of lower interest income from the debt portfolio. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Credit metrics continued to affect the results. The company recorded a net realized loss on investments of $11.3 million, or $0.17 per basic share, along with net unrealized depreciation of $29.1 million, or $0.44 per basic share. As a result, NAV per share dropped to $5.56 from $6.98 at the end of 2025. The dollar-weighted annualized yield on the debt portfolio was 14.7%, down from 18.6% a year earlier, even as onboarding yields improved to 12.6%.
Market Reaction and Investor Focus
Horizon shares have continued to trade at a meaningful discount to book value, which management has pointed to when explaining its $20 million stock repurchase program. During the quarter the company repurchased just over 2 million shares at an average price of $4.90. Investor attention ahead of the report centered on whether the portfolio could keep expanding while stressed credits showed signs of stabilization. The gap between NII per share and the combined regular and special distributions, together with the NAV decline, kept attention on credit quality rather than the headline income beat. The ongoing rise in rated-4 and rated-5 investments, which point to weaker credit quality and higher risk of principal loss, remains the main factor shaping sentiment.
What to Watch Going Forward
Looking ahead, the key item to monitor is whether Horizon can limit further losses on its stressed debt positions. Management has stressed active management of these holdings, yet any continued deterioration would add more pressure on NAV per share, which serves as a central valuation anchor for BDCs. On the positive side, the 14% sequential rise in the committed, approved, and awarded backlog to $351 million points to a stronger origination pipeline. With roughly $210.9 million in available liquidity and net leverage at 82% against a 120% target, the company still has room to put capital to work in new income-producing loans that could support future NII and distributions.
Investors will also want to keep an eye on the broader venture capital environment. Funding remains heavily tilted toward large artificial intelligence companies, which leaves the exit market for most technology and life sciences firms relatively quiet. That backdrop could affect both prepayment activity and the credit performance of Horizon’s portfolio companies in coming quarters. Distribution sustainability will stay in focus as well. With quarterly distributions still above current NII per share, the company’s ability to draw on spillover income, steadily rebuild earnings power, and benefit from the advisor’s fee waiver and any additional share repurchases will be watched closely.
Exploring AI Tools for Portfolio Monitoring
In my own process I often rely on Tickeron’s AI Screener to quickly filter opportunities and compare names like HRZN against peers using technical patterns, fundamentals, and AI signals. It helps surface ideas more efficiently than manual screening and supports a more structured approach to tracking BDC holdings alongside broader watchlists. The tool has become a regular part of how I review sector positioning and identify potential trade candidates without spending hours on spreadsheets.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Momentum Indicator for HRZN turns negative, indicating new downward trend
HRZN saw its Momentum Indicator move below the 0 level on October 13, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 73 similar instances where the indicator turned negative. In 43 of the 73 cases, the stock moved further down in the following days. The odds of a decline are at 59%.
Technical Analysis (Indicators)
Bearish Trend Analysis
HRZN moved below its 50-day moving average on October 05, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for HRZN crossed bearishly below the 50-day moving average on October 05, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 47%.
The 50-day moving average for HRZN moved below the 200-day moving average on October 23, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HRZN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.
The Aroon Indicator for HRZN entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where HRZN's RSI Oscillator exited the oversold zone, 23 of 47 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 49%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 29 of 59 cases where HRZN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 49%.
Following a +5.63% 3-day Advance, the price is estimated to grow further. Considering data from situations where HRZN advanced for three days, in 150 of 313 cases, the price rose further within the following month. The odds of a continued upward trend are 48%.
HRZN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 63 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 72 (best 1 - 100 worst), indicating slightly worse than average price growth. HRZN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 75 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.647) is normal, around the industry mean (2.440). P/E Ratio (10.892) is within average values for comparable stocks, (-3.350). Projected Growth (PEG Ratio) (1.907) is also within normal values, averaging (1.319). Dividend Yield (0.089) settles around the average of (0.267) among similar stocks. P/S Ratio (11.062) is also within normal values, averaging (15.694).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HRZN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a closed-end investment trust
Industry InvestmentManagers
Advertisement